Table 2 Primary and secondary outcomes.
Unmatched cohort n = 161 | PS-matched cohort n = 147 | |||||
|---|---|---|---|---|---|---|
CT | No CT | p value | CT | No CT | p value | |
Primary outcome | ||||||
24-h mortality, N (%) | 23 (17) | 8 (28) | 0.21 | 20 (17) | 7 (26) | 0.59 |
Secondary outcomes | ||||||
In hospital (30 days) mortality, N (%) | 38 (29) | 9 (31) | 0.81 | 30 (25) | 5 (20) | 0.68 |
Median overall length of stay, days [IQR] | 9 [1–22] | 9 [0–29] | 0.83 | 10 [1–26] | 9 [0–29] | 0.63 |
Median ICU stay, days [IQR] | 1 [0–11] | 1 [0–6] | 0.94 | 1 [0–6] | 1 [0–11] | 0.95 |
Massive transfusion, N (%) | 18 (14) | 5 (17) | 0.62 | 17 (14) | 5 (20) | 0.24 |
Median time to clear lactate, hours [IQR] | 17 [5–167] | 16 [6–167] | 0.95 | 14 [5–167] | 16 [6–167] | 0.93 |
